Optimization of chronic lymphocytic leukemia treatment using game theory
The current strategy of chronic lymphocytic leukemia (CLL) treatment is based on genetic risk factors such as del(17p), TP53 mutations and/or unmutated variant of IGHV genes. Guidelines recommend the usage of targeted drugs, e.g. ibrutinib, in the first line for patients with unfavorable risk factor...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Russo |
| Vydáno: |
Izdatelstvo OKI
2021-12-01
|
| Edice: | Качественная клиническая практика |
| Témata: | |
| On-line přístup: | https://www.clinvest.ru/jour/article/view/587 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|